Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

Immuneering Corporation - Special CallCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO & DirectorConference Call ...

Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...

Clinicians can present numbers to patients using numerical formats instead of vague words, fixed denominators, absolute ...

A new specialty bra store has opened in Normal, specializing in fittings and offering a wide range of sizes for women at every stage.

Learn how to calculate hazard rate, its practical implications in engineering and finance, and why it's critical in ...